Category Archives: Wherein

DC indefiniteness conclusion vacated for incorrect claim construction, grant of SJ regarding jurisdiction vacated

Posted on June 28, 2022 by Patrick J. Halloran, Ph.D., J.D.

Univ. of Massachusetts, Carmel Labs., LLC v. L’Oreal S.A. and L’Oreal USA, Inc. Docket No. 2020-1969 (https://cafc.uscourts.gov/opinions-orders/21-1969.OPINION.6-13-2022_1964183.pdf) PROST, MAYER, TARANTO June 13, 2022 Brief Summary:   DC indefiniteness finding vacated due to improper claim construction and grant of SJ for … Continue reading →

Posted in Claim Construction, Claim Differentiation, Infringement, Inter Parties Review (IPR), IPR, Prosecution History Estoppel, Wherein, Written description | Leave a comment

Board construction of “wherein” clause affirmed; remanded for review of non-instituted grounds

Posted on November 6, 2019 by Patrick J. Halloran, Ph.D., J.D.

Alere, Inc. v. Rembrandt Diagnostics, LP Docket Nos. 2018-1812 (IPR2016-01502) NEWMAN, DYK, REYNA October 29, 2019 Non-Precedential Brief Summary: Board’s claim construction of the “wherein” clause affirmed; decision remanded for consideration of non-instituted grounds. Summary: Alere appealed Board IPR final … Continue reading →

Posted in Claim Construction, Functional limitations, Inter Parties Review (IPR), IPR, Obviousness, Uncategorized, Wherein | Leave a comment

DC decision affirmed as safety and efficacy “wherein” clauses are limiting

Posted on September 24, 2019 by Patrick J. Halloran, Ph.D., J.D.

Allergan, Inc. et al. v. Sandoz, Inc., Alcon Laboratories Docket No. 2018-2207 PROST, NEWMAN, WALLACH August 29, 2019 Brief Summary: DC grant of a preliminary injunction to Allergan affirmed since the “wherein” clauses relating to safety and efficacy were found … Continue reading →

Posted in Claim Construction, Uncategorized, Wherein | Leave a comment